Scientists Schedule Second Secret Meeting of the Day
Published Date: 12/15/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in January 2026 to review important grant applications about addiction, HIV, vaccines, and cancer treatments. These meetings keep sensitive info private to protect ideas and personal details. Researchers and small businesses applying for grants should note these dates as they impact funding decisions.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Confidentiality of applications and personal data
The meetings will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because grant discussions could disclose confidential trade secrets, commercial property (including patentable material), and personal information. The closure is intended to protect applicants' proprietary information and personal privacy.
Closed NIH grant review meetings in January
The NIH Center for Scientific Review will hold multiple closed meetings in January 2026 (January 7, 12, 13, 14, 20, 23, 27, 27-28, and 29) to review and evaluate grant applications on topics such as addiction, HIV, vaccines, mental health, UG3 mechanisms, and biomedical devices. These meetings are closed to the public and are specifically listed with dates and times in the notice.
Dedicated small-business review panels scheduled
The notice lists dedicated Small Business Special Emphasis Panels on January 13, 2026 (Vaccines Against Infectious Diseases), January 14, 2026 (Immuno-oncology and Immunotherapy), January 27, 2026 (Biomaterials, Delivery, and Nanotechnology), and January 27-28, 2026 (Medical Imaging, Cardiovascular and Surgical Devices, Biomedical Sensing). If you are a small business applying in these areas, your applications are scheduled for review on those dates.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-22800, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 9, 2026, to review special grant applications related to new scientific projects. These meetings are private to protect secret ideas and personal info of applicants. Scientists applying for these grants should note the date and prepare, as this process helps decide who gets funding for exciting research.
Next: 2025-22802, Indian Gaming; Approval by Operation of Law of the Addendum to Tribal-State Compact for Control of Class III Blackjack on the Lower Sioux Community Reservation in the State of Minnesota for Class III Card Games
The Lower Sioux Community in Minnesota can now officially offer Class III blackjack and other card games on their reservation starting December 15, 2025. This change happened automatically because the government didn’t act within 45 days, so the new gaming rules are approved by default. It means more fun and potential money for the tribe without any delays or extra costs.